CLINICAL_TRIALS
research
· 2026-02-11
Clinical Trial Update: Bevacizumab Treatment For Type 1 ROP [Phase 2]
Summary
A Phase 2 trial of bevacizumab for Type 1 retinopathy of prematurity is ongoing. The study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Retinopathy of Prematurity | Phase 2 | Status: ACTIVE_NOT_RECRUITING